The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
OTLK
Outlook Therapeutics stock continues to rise another approximately 13% today
Completing a rise of approximately 30% since the report and close to 50% from the bottom.
Other Stories
Millions of dollars in CALL options on Moderna
PremiumOption WhalesMRNA2h ago1 min read
Unusual mega dark pool transaction on the S&P 500
PremiumBreaking2h ago1 min read
Microsoft introduces new AI chips and their impact on the market
PremiumBreakingTSM8h ago1 min read